A detailed history of Ctc Alternative Strategies, Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ctc Alternative Strategies, Ltd. holds 1,976 shares of MRK stock, worth $197,007. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,976
Holding current value
$197,007
% of portfolio
0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$111.15 - $128.97 $219,632 - $254,844
1,976 New
1,976 $224 Million
Q2 2023

Aug 23, 2023

BUY
$108.61 - $118.38 $222,650 - $242,679
2,050 New
2,050 $237 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ctc Alternative Strategies, Ltd. Portfolio

Follow Ctc Alternative Strategies, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc Alternative Strategies, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Ctc Alternative Strategies, Ltd. with notifications on news.